Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Calquence

(KAL-kwents)
A drug used alone to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma and adults with mantle cell lymphoma that has already been treated with at least one other therapy. Calquence is used with bendamustine and rituximab to treat adults with mantle cell lymphoma that has not been treated and who cannot receive an autologous stem cell transplant. It is also being studied in the treatment of other types of cancer. Calquence blocks a protein called BTK, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called acalabrutinib maleate monohydrate.
Search NCI's Dictionary of Cancer Terms